calcium carbonate 150 MG / prasterone 50 MG Oral Tablet
- RxCUI
- 1302637
- RxNorm name
- calcium carbonate 150 MG / prasterone 50 MG Oral Tablet
- Display name
- Calcium carbonate/Prasterone (Oral Pill)
- Full name
- calcium carbonate 150 MG / prasterone 50 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 150-50 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-29 06:02:27
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082012
- Active start
- 082012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| calcium carbonate | 150 MG / 1 EACH | calcium carbonate | calcium carbonate |
| prasterone sodium sulfate | 50 MG / 1 EACH | prasterone | prasterone sodium sulfate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| calcium carbonate | 1897 |
| prasterone | 3143 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | calcium carbonate 150 MG / prasterone 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | calcium carbonate 150 MG / prasterone 50 MG Oral Tablet | 1 | NAMES |
| RxNorm Synonym | calcium carbonate 150 MG (calcium 60 MG) / DHEA 50 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1302637 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | A14AA | Androstan derivatives | ATC1-4 | prasterone | |
| ATC | A12AA | Calcium | ATC1-4 | calcium carbonate | |
| ATC | A02AC | Calcium compounds | ATC1-4 | calcium carbonate | |
| ATC | G03XX | Other sex hormones and modulators of the genital system | ATC1-4 | prasterone | |
| MEDRT | D002119 | Calcium Carbonate | CHEM | has_ingredient | calcium carbonate |
| MEDRT | D003687 | Dehydroepiandrosterone | CHEM | has_ingredient | prasterone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | prasterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | calcium carbonate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | prasterone |
| MEDRT | D004381 | Duodenal Ulcer | DISEASE | may_treat | calcium carbonate |
| MEDRT | D004414 | Dyspareunia | DISEASE | may_treat | prasterone |
| MEDRT | D004415 | Dyspepsia | DISEASE | may_treat | calcium carbonate |
| MEDRT | D004942 | Esophagitis, Peptic | DISEASE | may_treat | calcium carbonate |
| MEDRT | D005764 | Gastroesophageal Reflux | DISEASE | may_treat | calcium carbonate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_prevent | calcium carbonate |
| MEDRT | D006471 | Gastrointestinal Hemorrhage | DISEASE | may_treat | calcium carbonate |
| MEDRT | D006356 | Heartburn | DISEASE | may_treat | calcium carbonate |
| MEDRT | D006934 | Hypercalcemia | DISEASE | ci_with | calcium carbonate |
| MEDRT | D006996 | Hypocalcemia | DISEASE | may_treat | calcium carbonate |
| MEDRT | D017674 | Hypophosphatemia | DISEASE | ci_with | calcium carbonate |
| MEDRT | D007669 | Kidney Calculi | DISEASE | ci_with | calcium carbonate |
| MEDRT | D007676 | Kidney Failure, Chronic | DISEASE | may_treat | calcium carbonate |
| MEDRT | D007774 | Lactation | DISEASE | ci_with | prasterone |
| MEDRT | D008177 | Lupus Vulgaris | DISEASE | may_treat | prasterone |
| MEDRT | D010024 | Osteoporosis | DISEASE | may_prevent | calcium carbonate |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_treat | calcium carbonate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | prasterone |
| MEDRT | D019968 | Sexual and Gender Disorders | DISEASE | may_treat | prasterone |
| MEDRT | D013276 | Stomach Ulcer | DISEASE | may_treat | calcium carbonate |
| MEDRT | N0000000226 | Acid-Base Activity | MOA | has_moa | calcium carbonate |
| MEDRT | N0000000220 | Electrolyte Activity | MOA | has_moa | calcium carbonate |
| MEDRT | N0000000223 | Mechanism of Action | MOA | has_moa | prasterone |
| MEDRT | N0000009915 | Unknown Cellular or Molecular Interaction | MOA | has_moa | prasterone |
| MEDRT | N0000008292 | Adrenal Medullary Activity Alteration | PE | has_pe | prasterone |
| MEDRT | N0000008312 | Bone Resorption Alteration | PE | has_pe | calcium carbonate |
| MEDRT | N0000009040 | Enhance Penile Erection | PE | has_pe | prasterone |
| MEDRT | N0000009054 | Gastric Acid Alteration | PE | has_pe | calcium carbonate |
| MEDRT | N0000009461 | Increased Ovarian Estrogen Secretion | PE | has_pe | prasterone |
| MEDRT | N0000009557 | Increased Renal PO4-- Excretion | PE | has_pe | calcium carbonate |
| MEDRT | N0000009694 | Increased Testosterone Secretion | PE | has_pe | prasterone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 150 MG / 50 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| NAMES | Prescribable Synonym | calcium 60 MG / dehydroepiandrosterone 50 MG Oral Tablet, as calcium carbonate |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |